← FDA Drug Approvals (Drugs@FDA)
KEYTRUDA QLEX
BLA · Biologics License Application · Sponsor: MERCK SHARP DOHME · Approved 2025-09-19
Drug application
- FDA Application #
BLA761467- Application type
- Biologics License Application
- Brand name
- KEYTRUDA QLEX
- Generic name
- PEMBROLIZUMAB AND BERAHYALURONIDASE ALFA-PMPH
- Active ingredients
- PEMBROLIZUMAB; BERAHYALURONIDASE ALFA-PMPH
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- MERCK SHARP DOHME
- Manufacturer
- Merck Sharp & Dohme LLC
- First approval
- 2025-09-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown